Publications

• Endocannabinoid modulation of defensive state transitions to innate and learned threat. Loomba N, Cao A, Charles S, Kandil I, Kwon M, Patel S. Psychopharmacology (Berl). 2026 Feb; 243(2): 325-338.

• Alcohol Withdrawal Alters the Inhibitory Landscape of the Prelimbic Cortex in an Interneuron- and Sex-specific Manner. Quadir SG, Zaidi SD, Cone MG, Patel S. Addict Neurosci. 2025 Dec; 17: 100237.

• Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation. Loomba N, Patel S. Nat Rev Neurosci. 2025 Nov; 26(11): 677-697.

• Synaptic organization and associative learning-related activity of basolateral amygdala interneurons. Báldi R, Muthuswamy S, Yasmin F, Quadir S, Zaidi D, Kwon M, Kandil I, Johnson K, Loomba N, Patel S. Cell Rep. 2025 Oct; 44(10): 116295.

• Prefrontal correlates of fear generalization during endocannabinoid depletion. Rosas-Vidal LE, Naskar S, Mayo LM, Perini I, Masroor R, Altemus M, Ramos-Medina L, Zaidi SD, Engelbrektsson H, Jagasia P, Heilig M, Patel S. J Clin Invest. 2025 Jun; 135(11): e179881.

• Pharmacological diacylglycerol lipase inhibition impairs contextual fear extinction in mice. Ramos-Medina L, Rosas-Vidal LE, Patel S. Psychopharmacology (Berl). 2024 Mar; 241(3): 569-584.

• A cortico-amygdala neural substrate for endocannabinoid modulation of fear extinction. Gunduz-Cinar O, Castillo LI, Xia M, Van Leer E, Brockway ET, Pollack GA, Yasmin F, Bukalo O, Limoges A, Oreizi-Esfahani S, Kondev V, Báldi R, Dong A, Harvey-White J, Cinar R, Kunos G, Li Y, Zweifel LS, Patel S, Holmes A. Neuron. 2023 Oct; 111(19): 3053-3067.e10.

• Endocannabinoid release at ventral hippocampal-amygdala synapses regulates stress-induced behavioral adaptation. Kondev V, Najeed M, Yasmin F, Morgan A, Loomba N, Johnson K, Adank DN, Dong A, Delpire E, Li Y, Winder D, Grueter BA, Patel S. Cell Rep. 2023 Sep; 42(9): 113027.

• Cannabidiol Differentially Modulates Synaptic Release and Cellular Excitability in Amygdala Subnuclei. Winters ND, Yasmin F, Kondev V, Grueter BA, Patel S. ACS Chem Neurosci. 2023 Jun; 14(11): 2008-2015.

• Opposing retrograde and astrocyte-dependent endocannabinoid signaling mechanisms regulate lateral habenula synaptic transmission. Winters ND, Kondev V, Loomba N, Delpire E, Grueter BA, Patel S. Cell Rep. 2023 Mar; 42(3): 112159.

• Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment. Scheyer A, Yasmin F, Naskar S, Patel S. Neuropsychopharmacology. 2023 Jan; 48(1): 37-53.

• Ventral hippocampal diacylglycerol lipase-alpha deletion decreases avoidance behaviors and alters excitation-inhibition balance. Kondev V, Bluett R, Najeed M, Rosas-Vidal LE, Grueter BA, Patel S. Neurobiol Stress. 2023 Jan; 22: 100510.

• The Endocannabinoid 2-Arachidonoylglycerol Bidirectionally Modulates Acute and Protracted Effects of Predator Odor Exposure. Kondev V, Morgan A, Najeed M, Winters ND, Kingsley PJ, Marnett L, Patel S. Biol Psychiatry. 2022 Nov; 92(9): 739-749.

• 2-Arachidonoylglycerol-mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice. Morgan A, Adank D, Johnson K, Butler E, Patel S. Alcohol Clin Exp Res. 2022 Nov; 46(11): 2010-2024.

• Longitudinal monitoring of prefrontal cortical ensemble dynamics reveals new insights into stress habituation. Patel S, Johnson K, Adank D, Rosas-Vidal LE. Neurobiol Stress. 2022 Sep; 20: 100481.

• Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers. Haney M, Bedi G, Cooper ZD, Herrmann ES, Reed SC, Foltin RW, Kingsley PJ, Marnett LJ, Patel S. Addict Biol. 2022 Jul; 27(4): e13183.

• Alcohol and Cannabinoids. Metrik J, Patel S. Alcohol Res. 2022; 42(1): 10.

• Cocaine restricts nucleus accumbens feedforward drive through a monoamine-independent mechanism.Manz KM, Coleman BC, Jameson AN, Ghose DG, Patel S, Grueter BA. Neuropsychopharmacology. 2022 Feb; 47(3): 652-663.

• Endogenous cannabinoids are required for MC4R-mediated control of energy homeostasis. Yong Y, Cakir I, Lining Pan P, Biddinger JE, Bluett RJ, Mackie K, Bingham N, Patel S, Ghamari-Langroudi M. Proc Natl Acad Sci U S A. 2021 Oct; 118(42).

• CaMKII Modulates Diacylglycerol Lipase-α Activity in the Rat Nucleus Accumbens after Incubation of Cocaine Craving. Murray CH, Gaulden AD, Kawa AB, Milovanovic M, Caccamise AJ, Funke JR, Patel S, Wolf ME. eNeuro. 2021 Sep; 8(5).

• In vivo endocannabinoid dynamics at the timescale of physiological and pathological neural activity. Farrell JS, Colangeli R, Dong A, George AG, Addo-Osafo K, Kingsley PJ, Morena M, Wolff MD, Dudok B, He K, Patrick TA, Sharkey KA, Patel S, Marnett LJ, Hill MN, Li Y, Teskey GC, Soltesz I. Neuron. 2021 Aug; 109(15): 2398-2403.e4.

• Targeting diacylglycerol lipase reduces alcohol consumption in preclinical models. Winters ND, Bedse G, Astafyev AA, Patrick TA, Altemus M, Morgan AJ, Mukerjee S, Johnson KD, Mahajan VR, Uddin MJ, Kingsley PJ, Centanni SW, Siciliano CA, Samuels DC, Marnett LJ, Winder DG, Patel S. J Clin Invest. 2021 Jul.

• Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches. Kondev V, Winters N, Patel S. Int Rev Neurobiol. 2021; 157: 143-193.

• The endocannabinoid system in humans: significant associations between anandamide, brain function during reward feedback and a personality measure of reward dependence. Redlich C, Dlugos A, Hill MN, Patel S, Korn D, Enneking V, Foerster K, Arolt V, Domschke K, Dannlowski U, Redlich R. Neuropsychopharmacology. 2021 Apr; 46(5): 1020-1027.

• "Corting" stress: post-stress corticosterone administration prevents delayed-onset biobehavioral consequences. Yasmin F, Patel S. Neuropsychopharmacology. 2020 Dec; 45(13): 2135-2136.

• Cyclooxygenase-2 inhibition prevents stress induced amygdala activation and anxiety-like behavior. Morgan A, Gaulden A, Altemus M, Williford K, Centanni S, Winder D, Patel S. Brain Behav Immun. 2020 Oct; 89: 513-517.

• 2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics. Bedse G, Hill MN, Patel S. Biol Psychiatry. 2020 Oct; 88(7): 520-530.

• α2A-adrenergic heteroreceptors are required for stress-induced reinstatement of cocaine conditioned place preference. Perez RE, Basu A, Nabit BP, Harris NA, Folkes OM, Patel S, Gilsbach R, Hein L, Winder DG. Neuropsychopharmacology. 2020 Aug; 45(9): 1473-1481.

• Arrested Development: A Story of How Perinatal Cannabinoids Affect the Maturation of the Prefrontal Cortex. Winters ND, Patel S. Biol Psychiatry. 2020 Apr; 87(7): 595-596.

• An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability.Folkes OM, Báldi R, Kondev V, Marcus DJ, Hartley ND, Turner BD, Ayers JK, Baechle JJ, Misra MP, Altemus M, Grueter CA, Grueter BA, Patel S. J Clin Invest. 2020 Apr; 130(4): 1728-1742.

• Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening. Marcus DJ, Bedse G, Gaulden AD, Ryan JD, Kondev V, Winters ND, Rosas-Vidal LE, Altemus M, Mackie K, Lee FS, Delpire E, Patel S. Neuron. 2020 Mar; 105(6): 1062-1076.e6.

• Dynamic remodeling of a basolateral-to-central amygdala glutamatergic circuit across fear states. Hartley ND, Gaulden AD, Báldi R, Winters ND, Salimando GJ, Rosas-Vidal LE, Jameson A, Winder DG, Patel S. Nat Neurosci. 2019 Dec; 22(12): 2000-2012.

• Cyclooxygenase-2 inhibition reduces anxiety-like behavior and normalizes enhanced amygdala glutamatergic transmission following chronic oral corticosterone treatment. Morgan A, Kondev V, Bedse G, Baldi R, Marcus D, Patel S. Neurobiol Stress. 2019 Nov; 11: 100190.

• Cocaine-induced endocannabinoid signaling mediated by sigma-1 receptors and extracellular vesicle secretion. Nakamura Y, Dryanovski DI, Kimura Y, Jackson SN, Woods AS, Yasui Y, Tsai S-Y, Patel S, Covey DP, Su T-P, Lupica CR. Elife. 2019 Oct; 8.

• Driving the Downward Spiral: Alcohol-Induced Dysregulation of Extended Amygdala Circuits and Negative Affect. Centanni SW, Bedse G, Patel S, Winder DG. Alcohol Clin Exp Res. 2019 Oct; 43(10): 2000-2013.

• Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder. Bedse G, Centanni SW, Winder DG, Patel S. Alcohol Clin Exp Res. 2019 Oct; 43(10): 2014-2027.

• Aspects of Prostaglandin Glycerol Ester Biology. Kingsley PJ, Rouzer CA, Morgan AJ, Patel S, Marnett LJ. Adv Exp Med Biol. 2019; 1161: 77-88.

• Leptin Receptor Signaling in Sim1-Expressing Neurons Regulates Body Temperature and Adaptive Thermogenesis. Cakir I, Diaz-Martinez M, Lining Pan P, Welch EB, Patel S, Ghamari-Langroudi M. Endocrinology. 2019 Apr; 160(4): 863-879.

• The association between endogenous opioid function and morphine responsiveness: a moderating role for endocannabinoids. Bruehl S, Burns JW, Morgan A, Koltyn K, Gupta R, Buvanendran A, Edwards D, Chont M, Kingsley PJ, Marnett L, Stone A, Patel S. Pain. 2019 Mar; 160(3): 676-687.

• Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence. Centanni SW, Morris BD, Luchsinger JR, Bedse G, Fetterly TL, Patel S, Winder DG. Neuropsychopharmacology. 2019 Feb; 44(3): 526-537.

• Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and Repetitive Behavior.Shonesy BC, Parrish WP, Haddad HK, Stephenson JR, Báldi R, Bluett RJ, Marks CR, Centanni SW, Folkes OM, Spiess K, Augustin SM, Mackie K, Lovinger DM, Winder DG, Patel S, Colbran RJ. Biol Psychiatry. 2018 Aug; 84(4): 304-315.

• Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain. Morgan AJ, Kingsley PJ, Mitchener MM, Altemus M, Patrick TA, Gaulden AD, Marnett LJ, Patel S. ACS Chem Neurosci. 2018 Jul; 9(7): 1552-1559.

• Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain. Wenzel JM, Oleson EB, Gove WN, Cole AB, Gyawali U, Dantrassy HM, Bluett RJ, Dryanovski DI, Stuber GD, Deisseroth K, Mathur BN, Patel S, Lupica CR, Cheer JF. Curr Biol. 2018 May; 28(9): 1392-1404.e5.

• Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors. Bedse G, Bluett RJ, Patrick TA, Romness NK, Gaulden AD, Kingsley PJ, Plath N, Marnett LJ, Patel S. Transl Psychiatry. 2018 Apr; 8(1): 92.

• Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder. Hill MN, Campolongo P, Yehuda R, Patel S. Neuropsychopharmacology. 2018 Jan; 43(1): 80-102.

• Inhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice. Cavener VS, Gaulden A, Pennipede D, Jagasia P, Uddin J, Marnett LJ, Patel S. Front Neurosci. 2018; 12: 479.

• Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety. Bedse G, Hartley ND, Neale E, Gaulden AD, Patrick TA, Kingsley PJ, Uddin MJ, Plath N, Marnett LJ, Patel S. Biol Psychiatry. 2017 Oct; 82(7): 488-499.

• Cannabis for Pain and Posttraumatic Stress Disorder: More Consensus Than Controversy or Vice Versa?Patel S. Ann Intern Med. 2017 Sep; 167(5): 355-356.

• A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members. Piomelli D, Cooper Z, Abrams D, Grant I, Patel S. Cannabis Cannabinoid Res. 2017; 2(1): 155-159.

• What We Do (and Don't) Know About the Health Effects of Cannabis and Whether Marijuana Is Medicine.Patel S, Williams JW, Wallace RB. Ann Intern Med. 2017 May; 166(10): 747-748.

• The endocannabinoid system as a target for novel anxiolytic drugs. Patel S, Hill MN, Cheer JF, Wotjak CT, Holmes A. Neurosci Biobehav Rev. 2017 May; 76(Pt A): 56-66.

• Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. Bluett RJ, Báldi R, Haymer A, Gaulden AD, Hartley ND, Parrish WP, Baechle J, Marcus DJ, Mardam-Bey R, Shonesy BC, Uddin MJ, Marnett LJ, Mackie K, Colbran RJ, Winder DG, Patel S. Nat Commun. 2017 Mar; 8: 14782.

• Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. Doenni VM, Gray JM, Song CM, Patel S, Hill MN, Pittman QJ. Brain Behav Immun. 2016 Nov; 58: 237-247.

• Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release. Foster DJ, Wilson JM, Remke DH, Mahmood MS, Uddin MJ, Wess J, Patel S, Marnett LJ, Niswender CM, Jones CK, Xiang Z, Lindsley CW, Rook JM, Conn PJ. Neuron. 2016 Sep; 91(6): 1244-1252.

• Acute and chronic ethanol exposure differentially regulate CB1 receptor function at glutamatergic synapses in the rat basolateral amygdala. Robinson SL, Alexander NJ, Bluett RJ, Patel S, McCool BA. Neuropharmacology. 2016 Sep; 108: 474-484.

• Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol Drinking. Holleran KM, Wilson HH, Fetterly TL, Bluett RJ, Centanni SW, Gilfarb RA, Rocco LER, Patel S, Winder DG. Neuropsychopharmacology. 2016 Jul; 41(8): 2062-2071.

• Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Reddy IA, Pino JA, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, Fink-Jensen A, Torres GE, Galli A. Transl Psychiatry. 2016 May; 6: e809.

• Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. Gamble-George JC, Baldi R, Halladay L, Kocharian A, Hartley N, Silva CG, Roberts H, Haymer A, Marnett LJ, Holmes A, Patel S. Elife. 2016 May; 5.

• Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids. Gunduz-Cinar O, Flynn S, Brockway E, Kaugars K, Baldi R, Ramikie TS, Cinar R, Kunos G, Patel S, Holmes A. Neuropsychopharmacology. 2016 May; 41(6): 1598-1609.

• The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models. Patel S, Shonesy BC, Bluett RJ, Winder DG, Colbran RJ. Biol Psychiatry. 2016 May; 79(10): e78-e79.

• Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function. Gray JM, Wilson CD, Lee TTY, Pittman QJ, Deussing JM, Hillard CJ, McEwen BS, Schulkin J, Karatsoreos IN, Patel S, Hill MN. Psychoneuroendocrinology. 2016 Apr; 66: 151-158.

• Electrophysiological Measurement of Cannabinoid-Mediated Synaptic Modulation in Acute Mouse Brain Slices. Báldi R, Ghosh D, Grueter BA, Patel S. Curr Protoc Neurosci. 2016 Apr; 75: 6.29.1-6.29.19.

• 2-arachidonoylglycerol signaling impairs short-term fear extinction. Hartley ND, Gunduz-Cinar O, Halladay L, Bukalo O, Holmes A, Patel S. Transl Psychiatry. 2016 Mar; 6: e749.

• Neurobiological Interactions Between Stress and the Endocannabinoid System. Morena M, Patel S, Bains JS, Hill MN. Neuropsychopharmacology. 2016 Jan; 41(1): 80-102.

• Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes. Brown JA, Ramikie TS, Schmidt MJ, Báldi R, Garbett K, Everheart MG, Warren LE, Gellért L, Horváth S, Patel S, Mirnics K. Mol Psychiatry. 2015 Dec; 20(12): 1499-1507.

• Prefrontal inputs to the amygdala instruct fear extinction memory formation. Bukalo O, Pinard CR, Silverstein S, Brehm C, Hartley ND, Whittle N, Colacicco G, Busch E, Patel S, Singewald N, Holmes A. Sci Adv. 2015 Jul; 1(6).

• The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium. Shonesy BC, Winder DG, Patel S, Colbran RJ. Neuropharmacology. 2015 Apr; 91: 57-62.

• Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. Gray JM, Vecchiarelli HA, Morena M, Lee TTY, Hermanson DJ, Kim AB, McLaughlin RJ, Hassan KI, Kühne C, Wotjak CT, Deussing JM, Patel S, Hill MN. J Neurosci. 2015 Mar; 35(9): 3879-3892.

• Neuroscience: a cellular basis for the munchies. Patel S, Cone RD. Nature. 2015 Mar; 519(7541): 38-40.

• Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. Shonesy BC, Bluett RJ, Ramikie TS, Báldi R, Hermanson DJ, Kingsley PJ, Marnett LJ, Winder DG, Colbran RJ, Patel S. Cell Rep. 2014 Dec; 9(5): 1644-1653.

• The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. Tchantchou F, Tucker LB, Fu AH, Bluett RJ, McCabe JT, Patel S, Zhang Y. Neuropharmacology. 2014 Oct; 85: 427-439.

• Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. Bluett RJ, Gamble-George JC, Hermanson DJ, Hartley ND, Marnett LJ, Patel S. Transl Psychiatry. 2014 Jul; 4: e408.

• Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation.Hermanson DJ, Gamble-George JC, Marnett LJ, Patel S. Trends Pharmacol Sci. 2014 Jul; 35(7): 358-367.

• Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. Ramikie TS, Nyilas R, Bluett RJ, Gamble-George JC, Hartley ND, Mackie K, Watanabe M, Katona I, Patel S. Neuron. 2014 Mar; 81(5): 1111-1125.

• Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Hermanson DJ, Hartley ND, Gamble-George J, Brown N, Shonesy BC, Kingsley PJ, Colbran RJ, Reese J, Marnett LJ, Patel S. Nat Neurosci. 2013 Sep; 16(9): 1291-1298.

• Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice. Gamble-George JC, Conger JR, Hartley ND, Gupta P, Sumislawski JJ, Patel S. Psychopharmacology (Berl). 2013 Aug; 228(3): 401-409.

• Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B, Godlewski G, Ramikie TS, Gorka AX, Alapafuja SO, Nikas SP, Makriyannis A, Poulton R, Patel S, Hariri AR, Caspi A, Moffitt TE, Kunos G, Holmes A. Mol Psychiatry. 2013 Jul; 18(7): 813-823.

• CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling. Shonesy BC, Wang X, Rose KL, Ramikie TS, Cavener VS, Rentz T, Baucum AJ, Jalan-Sakrikar N, Mackie K, Winder DG, Patel S, Colbran RJ. Nat Neurosci. 2013 Apr; 16(4): 456-463.

• Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress. Ramikie TS, Patel S. Neuroscience. 2012 Mar; 204: 38-52.

• High times for low-frequency stimulation as endocannabinoids engage in hippocampal long-term depression. Patel S. Neuropsychopharmacology. 2012 Feb; 37(3): 583-585.

• Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Sumislawski JJ, Ramikie TS, Patel S. Neuropsychopharmacology. 2011 Dec; 36(13): 2750-2761.

• An odyssey of fear: Homer stresses new mechanisms. Patel S, Winder DG. Biol Psychiatry. 2010 Dec; 68(11): 980-981.

• Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. Ho W-S, Patel S, Thompson JR, Roberts CJ, Stuhr KL, Hillard CJ. Br J Pharmacol. 2010 Jun; 160(3): 736-746.

• Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. Mozhui K, Karlsson R-M, Kash TL, Ihne J, Norcross M, Patel S, Farrell MR, Hill EE, Graybeal C, Martin KP, Camp M, Fitzgerald PJ, Ciobanu DC, Sprengel R, Mishina M, Wellman CL, Winder DG, Williams RW, Holmes A. J Neurosci. 2010 Apr; 30(15): 5357-5367.

• Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress. McElligott ZA, Klug JR, Nobis WP, Patel S, Grueter BA, Kash TL, Winder DG. Proc Natl Acad Sci U S A. 2010 Feb; 107(5): 2271-2276.

Books and Book Chapters

Endocannabinoid signaling and stress resilience
Hill MN, Patel S
Stress Resilience: Molecular and Behavioral Aspects. 2019 Nov; 349-362.
https://doi.org/10.1016/B978-0-12-813983-7.00022-7
ISBN: 9780128139837

Pharmacology of drugs of abuse
Martin PR, Patel S
Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy: Fourth Edition. 2016 Feb;
ISBN: 9781451191004

Pharmacology of drugs of abuse
Martin PR, Patel S, Swift RM
Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy: Third Edition. 2012 Oct; 641-688.
ISBN: 9781608312702